Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02822092 · ClinicalTrials.gov registry record
Striatal Connectivity and Clinical Outcome in Psychosis
A clinical trial, sponsored by Northwell Health.
- Completed
- Registry status
- 196
- Enrollment target
NCT02822092: Completed study, sponsored by Northwell Health.
NCT02822092 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 196 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02822092 has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 196 participants
- Enrollment target
Study Summary
This is an observational neuroimaging treatment study. This study involves examining the neural circuitry of controlled treatment of patients presenting with a first-episode of psychosis with risperidone or aripiprazole. Patients who present for treatment of a first psychotic episode with a schizophrenia spectrum diagnosis and who are eligible to undergo treatment with either risperidone or aripiprazole will be offered participation in the study. Clinical ratings, neuropsychological testing, neuroimaging and EEG will be conducted at baseline. Additionally, subjects will undergo the same assessments at week 12 to determine treatment-related biomarkers. Clinical ratings, including neurocognitive testing, will be conducted by blinded raters at study visits during treatment. Healthy controls (N=50) will also be recruited and scanned twice (12-week interval) to control for effects of time and practice.
Primary Outcome
To examine the efficacious treatment of psychotic symptoms with either risperidone or aripiprazole measured by specific items on the Brief Psychiatric Rating Scale - conceptual disorganization, grandiosity, hallucinatory behavior, unusual thought content
Interventions
- DRUG Risperidone or Aripiprazole (patients only)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 196 participants |
| Start Date | 2016-07 |
| Est. Completion | 2023-12 |
What the finished NCT02822092 record still lists
NCT02822092 is an observational study that tracks outcomes without assigning an intervention. The registered 196 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Risperidone or Aripiprazole (patients only) is the first listed.
NCT02822092 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02822092 about?
NCT02822092 is a clinical study titled "Striatal Connectivity and Clinical Outcome in Psychosis". This is an observational neuroimaging treatment study. This study involves examining the neural circuitry of controlled treatment of patients presenting with a first-episode of psychosis with risperidone or aripiprazole. Patients who present for treatment of a first psychotic episode with a schizoph...
What is the current status of trial NCT02822092?
This trial is currently completed. The enrollment target is 196 participants. The study started on 2016-07. Estimated completion is 2023-12.
What interventions are being tested in trial NCT02822092?
The interventions under investigation include: Risperidone or Aripiprazole (patients only) (DRUG).
Who is sponsoring clinical trial NCT02822092?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02822768 · 196 participants · NA
Packing Versus no Packing for Cutaneous Abscess
- NCT04250259 · 196 participants · Phase 2
SAMe Trial for Patients With Alcoholic Cirrhosis
- NCT05142592 · 196 participants · Phase 1
Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors
- NCT05317832 · 196 participants · Phase 2
Using Smartphones to Improve Physical Activity Levels of Individuals With Spinal Cord Injury
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia